Policy & Market
Sep 10, 2026 · 1 min read · 90,689 views
HHS rolls out sweeping clinical trial reforms to counter China, RFK Jr. says
L
Liam Turner
Editorial · Sep 10, 2026
Reports indicate that the Trump administration is responding to a drumbeat of calls from the biotech and pharma industries to modernize and expedite clinical trials with a sweeping initiative across HHS
← Previous
Vera eyes full approval for Trutakna in IgAN following positive readout
Next →
Pfizer, Lilly 'most favored nation' deals to give US share of revenue from raised foreign prices
